Association between telomere length and Parkinson's disease: a Mendelian randomization study

Area of Science:

• Genetics
• Neurodegenerative Diseases
• Epidemiology

Background:

• Telomere length is a biomarker of cellular aging.
• Parkinson's disease (PD) is a complex neurodegenerative disorder with multifactorial causes.
• Previous studies have explored associations between telomere length and various diseases, but causal links remain debated.

Purpose of the Study:

• To investigate the potential causal association between genetically predicted telomere length and the risk of Parkinson's disease (PD).
• To leverage Mendelian randomization to infer causality and overcome limitations of observational studies.

Main Methods:

• Utilized summary statistics from a large genome-wide association study (GWAS) for Parkinson's disease (up to 37,688 cases and 449,056 controls).
• Employed Mendelian randomization (MR) analysis, a genetic epidemiological method, to assess the causal effect of telomere length on PD risk.
• Instrumental variables were derived from single nucleotide polymorphisms (SNPs) associated with telomere length.

Main Results:

• The Mendelian randomization analysis did not reveal a statistically significant association between genetically predicted longer telomere length and an increased risk of Parkinson's disease.
• The estimated odds ratio for PD per unit increase in telomere length was 1.18 (95% CI: 0.94, 1.48; p = 0.15).

Conclusions:

• This study provides no evidence for a causal relationship between telomere length and the risk of developing Parkinson's disease.
• The findings suggest that telomere length may not be a direct causal risk factor for PD, despite potential observational correlations.